Table 3 Clinical efficacy of CPPs compared to PCPs
CPP | PCP | p-value* | |
|---|---|---|---|
Number (%) of patients with BP at goal | |||
Beginning of study | 36 (57.1) | 30 (47.6) | 0.48 |
End of Study | 40 (63.5) | 29 (46.0) | |
Number (%) of patients with HgbA1c at goal | |||
Beginning of study | 2 (7.1) | 22 (61.1) | 0.21 |
End of Study | 7 (25.0) | 23 (63.9) | |
Number (%) of patients with pain at goal | |||
BPI score decreased by 1 point | 26 (55.3) | 13 (41.9) | 0.30 |
BPI score decreased by 2 points | 20 (40.4) | 10 (32.2) | 0.47 |